Armor Pharma is marking its 10th anniversary this year, having launched at CPHI Paris in 2014. For this year’s event, Armor Pharma is partnering with MEDELPHARM to showcase the performance of their lactose excipients, EXCIPRESS™ GR150 and EXCIPRESS™ SDL2, through live demonstrations at their booth.
The STYL'One Nano is a state-of-the-art R&D compaction simulator capable of performing full compaction analysis during early powder characterization and formulation development stages. It enables the compaction properties assessment of excipients, APIs or formulations, making it an essential tool for pharmaceutical companies looking to streamline the tableting development process. With its flexibility and precision, the STYL'One Nano is ideal for testing challenging formulations and optimizing tablet properties, all while minimizing material usage during trials.
At the event, MEDELPHARM’s Science Lab expert, Adrien Pelloux, will be on-site conducting two live demonstrations using Armor’s EXCIPRESS™ lactose grades:
- “Secure scale-up with non-speed sensitive lactose”, which focuses on ensuring a smooth transition from small-scale to large-scale production.
- “Ensure dosage uniformity of mini tablets thanks to high-flowability lactose”, demonstrating how MEDELPHARM’s technology ensures robust minitablets development.
These demonstrations will highlight how the STYL'One Nano Compaction Simulator works effortlessly with Armor’s lactose excipients to deliver reliable results in tablet formulation and production.
KORSCH & MEDELPHARM serve a diverse range of customer needs, from grams to tons, across every stage of the tableting process. From R&D to scale-up, to full scale production, a comprehensive range of machines and tablet compression expertise are here to support you.
Manuel Lucas, KORSCH area sales manager, will be on-site to discuss your tablet production projects and challenges.
CPHI is one of the most important global events for the pharmaceutical industry, bringing together professionals from across the sector to explore new innovations and foster collaborations. The 2024 edition, held in Milan, will focus on emerging trends in pharmaceutical technology, sustainability, and regulatory developments, providing a platform for thought leadership and networking. With over 1,800 exhibitors from more than 170 countries, it’s the perfect place to discover the latest in pharma.
MEDELPHARM and Armor Pharma’s collaboration at CPHI 2024 in Milan highlights both companies’ commitment to advancing pharmaceutical technology. Whether you are interested in the latest excipient innovations or the cutting-edge tablet compression capabilities of the STYL'One Nano, be sure to visit us at booth 6F59 for expert insights, live demonstrations, and a chance to connect with our team. Together, we are shaping the future of pharmaceutical production.
MEDELPHARM is a KORSCH company, MEDELPHARM is a KORSCH company, and the STYL’One Nano and STYL’One Evo are distributed via KORSCH AG, KORSCH America, Inc., KORSCH India Ltd., and MEDELPHARM Distribution.
